The financials sector is the last major GICS sector to get a dedicated Stoxcraft coverage article. The data was worth waiting for: this sector is not moving as a unit. It's splitting fast.
Financials sector score overview this week
Performance Score: 5.4 / 10
Average Risk Score: 4.8 / 10 (higher = more risk)
Stocks with upward TrendMeter signal: 9
Top BuyMeter classification by count: Buy
The average Health Score of 6.1 sits above the cross-universe median of 5.0. Fundamentals are broadly solid, but that average hides a significant spread between subsectors. Exchange operators are pulling the performance reading up. Banks are dragging it down.
Nine financials stocks carry an upward trend signal right now. The most common entry signal is Buy. The data isn't flashing a sector-wide alarm. It's pointing at specific names.
Three core scores
50+
Metrics feed into the three Core Scores: Health, Performance, and Risk
Current news driving financials scores
The Fed's rate meeting cycle is the dominant macro force shaping this sector. Markets are pricing in a delayed first cut, keeping rate volatility elevated longer than most expected. For exchange operators, that's a direct revenue tailwind: rate uncertainty drives derivatives trading volume up.
For banks, the same environment is punishing. Major lenders are building reserves against commercial real estate losses. Reuters reporting on rising US bank credit provisions confirms this pattern is sector-wide. That compresses profitability metrics and flows straight into lower Health Scores. Sector rotation away from bank stocks is already visible: Cboe gained 22 points this cycle. BAC lost 13. That's not noise.
Top 5 financials stocks by Stoxcraft score
These five names rank highest across Health, Performance, and risk-adjusted contribution right now. Every one of them is a non-bank business.
CME Group (CME)
CME Group (CME) leads the financials sector. Health is in the top 10% of all financials stocks globally, driven by free cash flow conversion that outpaces most exchange peers. Performance ranks in the top quartile of the full Stoxcraft universe across multi-year horizons. Risk is low-to-moderate with a drawdown record well below sector average. Entry signal: Buy.
Cboe Global Markets (CBOE)
Cboe (CBOE) earned the biggest score jump in the sector this cycle: 22 points. Health is in the top 15% of financials globally, with net profit margins that consistently outpace capital markets peers. The technical picture is the strongest it's been in over a year. Entry signal: Buy.
Intercontinental Exchange (ICE)
Intercontinental Exchange (ICE) is the third exchange operator in the top 5. Health is in the top 20% of financials globally, with revenue compounding above the sector average over five years. The 5-year relative performance against the S&P 500 is the dominant score driver. Risk profile is moderate.
S&P Global (SPGI)
S&P Global (SPGI) earns its place on Health alone: top 10% of financials globally. Net profit margins dwarf sector peers and earnings consistency is among the highest in the sector. Performance has compounded above the S&P 500 over the 3-year and 5-year windows. Entry signal: Buy.
Visa (V)
Visa (V) closes the top 5. Health is in the top 10% of financials globally, driven by exceptional free cash flow conversion and minimal credit exposure. Both factors directly benefit the risk reading. Entry signal: Buy, anchored by strong analyst rating consensus.
Stocks to watch in financials
Mastercard (MA) sits just outside the top 5 with a profile nearly identical to Visa's. One strong momentum cycle could push it in. Bank of America (BAC) and Wells Fargo (WFC) both dropped 13 points this cycle. Health Scores are sliding below the sector median and trend signals are pointing down. Cheap valuations inside a weakening score environment is a well-known trap. Watch the next earnings cycle before making moves.
Why exchange operators are outranking every bank in the 2026 financials sector
Exchanges profit when markets move. Banks profit when credit is cheap and growing. The current environment is the opposite of what banks need and exactly what benefits CME and Cboe.
Exchange and data businesses have outperformed traditional lenders on return on equity for the past decade. Wall Street Journal analysis of financials sector trends confirms the pattern holds across market cycles. The Stoxcraft data captures that divergence in real time. Until the rate cycle turns, the scores will keep rewarding capital-light, high-margin businesses. None of the top 5 right now are banks.